Recent studies have demonstrated that the new Silverstone imaging device by Optos, which combines ultra-widefield (UWF) fundus capture with optomap guided swept-source optical coherence tomography (OCT), can improve patient management and change treatment decisions.
One study reported on a consecutive case series designed to evaluate the clinical utility of optomap-guided SSOCT across a variety of retinal diseases. The study found that optomap guided OCT imaging impacted clinical decision making in 84% of cases;1 69% of cases had pathology only in the periphery while 31% had pathology in the central pole.1 Additionally, UWF guided OCT assisted in diagnosis and guided patient management decisions.1
A second study looked at the clinical significance of peripheral OCT imaging with Silverstone, and found in 38% of cases, optomap navigated SS-OCT directly contributed to patient management plans.2
The multi-functional device is yet to be officially launched in Australia and New Zealand, however Optos reports some clinicians have installed them and are impressed with the device’s features, image clarity and increased practice efficiency.
Adelaide ophthalmologist Dr David Sia commented, “We chose the Silverstone because we wanted to have a SS-OCT in our clinic.
“We already love the Optos UWF and combined with SSOCT found it very easy to use. It definitely helps with diagnosis, mostly for peripheral retinal conditions.”
References
- Feasibility of peripheral OCT imaging using a novel integrated SLO ultra-widefield imaging swept-source OCT device. International Ophthalmology, 2021.
- Feasibility and Clinical Utility of Ultra-Widefield–Navigated Swept-Source Optical Coherence Tomography Imaging. Journal of VitreoRetinal Diseases, 2021.
